BiP (GRP78)
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">BiP (GRP78)</th>
</tr>
<tr>
<td class="label">Molecule</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[IRE1](/proteins/ire1)</td>
<td>Regulates activation</td>
</tr>
<tr>
<td class="label">PERK</td>
<td>Regulates activation</td>
</tr>
<tr>
<td class="label">ATF6</td>
<td>Regulates activation</td>
</tr>
<tr>
<td class="label">[Calreticulin](/proteins/calreticulin-protein)</td>
<td>Collaborates in ER</td>
</tr>
<tr>
<td class="label">Protein disulfide isomerase</td>
<td>Collaborates</td>
</tr>
<tr>
<td class="label">Derlins</td>
<td>Retrotranslocation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/bipolar" style="color:#ef9a9a">Bipolar</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">160 edges</a></td>
</tr>
</table>
BiP is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
...
BiP (GRP78)
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">BiP (GRP78)</th>
</tr>
<tr>
<td class="label">Molecule</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[IRE1](/proteins/ire1)</td>
<td>Regulates activation</td>
</tr>
<tr>
<td class="label">PERK</td>
<td>Regulates activation</td>
</tr>
<tr>
<td class="label">ATF6</td>
<td>Regulates activation</td>
</tr>
<tr>
<td class="label">[Calreticulin](/proteins/calreticulin-protein)</td>
<td>Collaborates in ER</td>
</tr>
<tr>
<td class="label">Protein disulfide isomerase</td>
<td>Collaborates</td>
</tr>
<tr>
<td class="label">Derlins</td>
<td>Retrotranslocation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/bipolar" style="color:#ef9a9a">Bipolar</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">160 edges</a></td>
</tr>
</table>
BiP is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
Binding immunoglobulin protein (BiP), also known as glucose-regulated protein 78 (GRP78) or HSPA5, is a master endoplasmic reticulum (ER) chaperone and central regulator of the [unfolded protein response](/entities/unfolded-protein-response) (UPR). BiP is essential for protein folding, calcium binding, and ER stress signaling, playing critical roles in neurodegeneration where ER stress is a prominent feature.
Structure and Function
Molecular Architecture
BiP is a 70-kDa heat shock protein family member consisting of[@haas1983]:
- Nucleotide-binding domain (NBD): Binds and hydrolyzes ATP
- Substrate-binding domain (SBD): Interacts with unfolded proteins
- Lid domain: Covers the SBD in the ATP-bound state
- C-terminal ER retention signal (KDEL): Maintains ER localization
Chaperone Mechanism
BiP functions through an ATP-dependent chaperone cycle[@mayer2005]:
ATP-bound state: Low affinity for substrates, rapid exchange
ATP hydrolysis: Converts to ADP-bound high-affinity state
Substrate binding: Binds exposed hydrophobic regions of unfolded proteins
Nucleotide exchange: Releases substrate for folding attempts
Cycling: Repeats until proper folding or degradationUnfolded Protein Response (UPR)
BiP is the master regulator of the UPR[@bertolotti2000]:
- Basal state: BiP binds to ER stress sensors (IRE1, PERK, ATF6), keeping them inactive
- ER stress: Unfolded proteins compete for BiP binding
- Sensor activation: Released sensors initiate UPR signaling
- Adaptive response: Increased chaperone production and protein degradation
Role in Neurodegeneration
ER Stress in Neurodegeneration
ER stress is a hallmark of neurodegenerative diseases[@scheper2015]:
- Accumulation of misfolded proteins ([Aβ](/proteins/amyloid-beta), [tau](/proteins/tau), α-synuclein)
- Chronic UPR activation
- BiP induction as compensatory response
- Transition from protective to apoptotic signaling
Alzheimer's Disease
In [Alzheimer's disease](/diseases/alzheimers-disease), BiP plays complex roles[@hoozemans2007]:
- Upregulated in affected brain regions
- Interacts with [amyloid precursor protein](/entities/app-protein) (APP)
- May modulate Aβ production
- Chronic ER stress overwhelms chaperone capacity
BiP and Tau Pathology
BiP interacts with [tau](/proteins/tau)[@gupta2021]:
- Binds misfolded tau species
- May prevent tau aggregation
- UPR activation in tauopathy models
- Potential therapeutic target
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease)[@smith2020]:
- BiP upregulation in dopaminergic [neurons](/entities/neurons)
- [α-Synuclein](/proteins/alpha-synuclein) accumulation induces ER stress
- BiP may protect against α-synuclein toxicity
- PERK/ATF4 pathway activation
Amyotrophic Lateral Sclerosis
In [ALS](/diseases/amyotrophic-lateral-sclerosis)[@ilieva2007]:
- Mutant SOD1 aggregates induce ER stress
- BiP levels increase as protective response
- [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology associated with UPR activation
- Chaperone-based therapeutic approaches
Prion Diseases
In prion diseases[@hetz2003]:
- Prion protein misfolding triggers ER stress
- BiP expression correlates with disease stage
- UPR mediates neurotoxicity
- Target for therapeutic intervention
UPR Sensor Regulation
BiP binds to and regulates three UPR sensors[@walter2011]:
IRE1 (ERN1)
[BiP binds to the luminal domain of IRE1](/proteins/ire1):
- ER stress releases BiP from IRE1
- IRE1 dimerizes and autophosphorylates
- Initiates XBP1 splicing pathway
- Activates JNK and inflammatory responses
PERK (EIF2AK3)
BiP binding keeps PERK inactive:
- Stress releases PERK
- PERK phosphorylates eIF2α
- Reduces general translation, increases ATF4
- Activates [autophagy](/entities/autophagy) and antioxidant responses
ATF6
BiP binding retains ATF6 in the ER:
- Stress releases ATF6
- ATF6 translocates to Golgi for cleavage
- Cleaved ATF6 acts as transcription factor
- Induces chaperones including BiP itself
Therapeutic Implications
BiP Enhancers
Strategies to boost BiP activity[@gupta2021a]:
- Chemical chaperones: 4-phenylbutyrate, tauroursodeoxycholic acid (TUDCA)
- Gene therapy: BiP overexpression in animal models
- Small molecule activators: Modulating ATPase cycle
- ER proteostasis regulators: BIX compounds
UPR Modulation
Targeting UPR pathways[@wang2014]:
- PERK inhibitors: GSK2606414, GSK2656157
- IRE1 modulators: Kinase inhibitors, RNase modulators
- ATF6 activators: Enhanced chaperone production
- Balancing protection vs. [apoptosis](/entities/apoptosis)
Chemical Chaperones in Clinical Use
Several chemical chaperones are in clinical trials[@lee2019]:
- TUDCA: [Bile acid with chaperone activity](/therapeutics/tudca-udca-neurodegeneration)
- 4-PBA: FDA-approved for urea cycle disorders
- Potential applications: Neurodegenerative disease trials
BiP as a Biomarker
Diagnostic Potential
BiP levels may indicate ER stress status[@lajoie2019]:
- Increased CSF BiP in neurodegeneration
- Correlation with disease progression
- May predict response to therapy
- Blood levels reflect systemic ER stress
Research Applications
BiP reporters are used in research[@samali2008]:
- Fluorescent BiP fusion proteins
- ER stress sensors
- Drug screening platforms
- Disease model characterization
Interaction with Other Molecules
Research Directions
Current research focuses on:
BiP-specific activators for neurodegeneration
ER proteostasis network modulation
UPR sensor-specific interventions
BiP-based gene therapy approaches
Combination with protein degradation enhancers
Chemical chaperone optimizationSee Also
- [Alzheimer's disease](/diseases/alzheimers-disease)
- [Parkinson's disease](/diseases/parkinsons-disease)
- [ALS](/diseases/amyotrophic-lateral-sclerosis)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
[Haas IG, Wabl M, Immunoglobulin heavy chain binding protein (1983)](https://pubmed.ncbi.nlm.nih.gov/6951523/)
[Mayer MP, Bukau B, Hsp70 chaperones: cellular functions and molecular mechanism (2005)](https://pubmed.ncbi.nlm.nih.gov/15952854/)
[Bertolotti A et al, Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response (2000)](https://pubmed.ncbi.nlm.nih.gov/10809667/)
[Scheper W, Hoozemans JJM, The unfolded protein response in neurodegenerative diseases: a neuropathological perspective (2015)](https://pubmed.ncbi.nlm.nih.gov/25573153/)
[Hoozemans JJM et al, Activation of the unfolded protein response in Parkinson's disease (2007)](https://pubmed.ncbi.nlm.nih.gov/17681367/)
[Gupta MK, Taly R, BiP: a key chaperone involved in the tau pathology (2021)](https://pubmed.ncbi.nlm.nih.gov/34126673/)
[Smith HL, Mallucci GR, The unfolded protein response: triggers and modifiers in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32433963/)
[Ilieva EV et al, Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis (2007)](https://pubmed.ncbi.nlm.nih.gov/17185117/)
[Hetz C, Soto C, Unfolding the role of protein misfolding in neurodegenerative diseases (2003)](https://pubmed.ncbi.nlm.nih.gov/14691431/)
[Walter P, Ron D, The unfolded protein response: from stress pathway to homeostatic regulation (2011)](https://pubmed.ncbi.nlm.nih.gov/21727850/)
[Gupta MK et al, BiP as a therapeutic target in neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/33984256/)
[Wang M, Kaufman RJ, The impact of the endoplasmic reticulum protein-folding environment on cancer development (2014)](https://pubmed.ncbi.nlm.nih.gov/24874467/)
[Lee YS et al, Chemical chaperones for protein misfolding diseases (2019)](https://pubmed.ncbi.nlm.nih.gov/30640623/)
[Lajoie P, Snapp EL, BiP/GRP78 in neurodegeneration: a chaperone at the intersection of health and disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30987101/)
[Samali A et al, Methods to monitor endoplasmic reticulum stress and the unfolded protein response (2008)](https://pubmed.ncbi.nlm.nih.gov/18817554/)